FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005040232> ?p ?o ?g. }

• W2005040232 endingPage "674" @default.
• W2005040232 startingPage "670" @default.
• W2005040232 abstract "Objectives: To investigate whether perioperative Sonoclot analyses could identify differences in hemostatic function between a group of patients with unstable coronary artery disease treated with low–molecular-weight heparin until the evening before surgery and a group of patients with stable coronary artery disease not treated with low–molecular-weight heparin. Design: Prospective and observational investigation. Setting: A university hospital, single institution. Participants: Patients scheduled for coronary artery bypass surgery. Interventions: Blood samples for Sonoclot analysis were drawn preoperatively, 5 minutes after the administration of heparin, immediately after and 20 minutes after cardiopulmonary bypass was established, and 30 minutes and 3 and 20 hours after the end of surgery in a group of patients with unstable coronary artery disease and a group of patients with stable coronary artery disease. Measurements and Main Results: The Sonoclot variables sonACT, coagulation rate, time to peak, amplitude of the peak, and R3 were recorded. The sonACT was significantly lower in the enoxaparin group compared with the control group, whereas the coagulation rate was significantly higher in the enoxaparin group. There were no statistically significant differences in time to peak, amplitude of the peak, and R3 between the 2 study groups. Conclusions: The presence of a hypercoagulable state in patients with unstable coronary artery disease is indicated by the significantly higher coagulation rate observed in this group compared with the control group. Further larger studies are needed for evaluation of the usefulness of Sonoclot analysis in the monitoring of hemostatic function in patients with unstable coronary artery disease. Objectives: To investigate whether perioperative Sonoclot analyses could identify differences in hemostatic function between a group of patients with unstable coronary artery disease treated with low–molecular-weight heparin until the evening before surgery and a group of patients with stable coronary artery disease not treated with low–molecular-weight heparin. Design: Prospective and observational investigation. Setting: A university hospital, single institution. Participants: Patients scheduled for coronary artery bypass surgery. Interventions: Blood samples for Sonoclot analysis were drawn preoperatively, 5 minutes after the administration of heparin, immediately after and 20 minutes after cardiopulmonary bypass was established, and 30 minutes and 3 and 20 hours after the end of surgery in a group of patients with unstable coronary artery disease and a group of patients with stable coronary artery disease. Measurements and Main Results: The Sonoclot variables sonACT, coagulation rate, time to peak, amplitude of the peak, and R3 were recorded. The sonACT was significantly lower in the enoxaparin group compared with the control group, whereas the coagulation rate was significantly higher in the enoxaparin group. There were no statistically significant differences in time to peak, amplitude of the peak, and R3 between the 2 study groups. Conclusions: The presence of a hypercoagulable state in patients with unstable coronary artery disease is indicated by the significantly higher coagulation rate observed in this group compared with the control group. Further larger studies are needed for evaluation of the usefulness of Sonoclot analysis in the monitoring of hemostatic function in patients with unstable coronary artery disease." @default.
• W2005040232 created "2016-06-24" @default.
• W2005040232 creator A5011372943 @default.
• W2005040232 creator A5018805143 @default.
• W2005040232 creator A5034393425 @default.
• W2005040232 creator A5081082310 @default.
• W2005040232 date "2008-10-01" @default.
• W2005040232 modified "2023-10-17" @default.
• W2005040232 title "Sonoclot Analysis in Coronary Artery Surgery: A Comparison Between Patients With Unstable Coronary Artery Disease Treated With Enoxaparin Before Surgery and Patients With Stable Coronary Artery Disease Not Treated With Enoxaparin" @default.
• W2005040232 cites W1554752703 @default.
• W2005040232 cites W1581187193 @default.
• W2005040232 cites W1929629475 @default.
• W2005040232 cites W2032105970 @default.
• W2005040232 cites W2047897901 @default.
• W2005040232 cites W2049443810 @default.
• W2005040232 cites W2057492075 @default.
• W2005040232 cites W2100205908 @default.
• W2005040232 cites W2112154395 @default.
• W2005040232 cites W2114503532 @default.
• W2005040232 cites W2149599987 @default.
• W2005040232 cites W2157261949 @default.
• W2005040232 cites W2316460201 @default.
• W2005040232 cites W4233250209 @default.
• W2005040232 doi "https://doi.org/10.1053/j.jvca.2007.12.024" @default.
• W2005040232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18922421" @default.
• W2005040232 hasPublicationYear "2008" @default.
• W2005040232 type Work @default.
• W2005040232 sameAs 2005040232 @default.
• W2005040232 citedByCount "2" @default.
• W2005040232 countsByYear W20050402322012 @default.
• W2005040232 crossrefType "journal-article" @default.
• W2005040232 hasAuthorship W2005040232A5011372943 @default.
• W2005040232 hasAuthorship W2005040232A5018805143 @default.
• W2005040232 hasAuthorship W2005040232A5034393425 @default.
• W2005040232 hasAuthorship W2005040232A5081082310 @default.
• W2005040232 hasConcept C126322002 @default.
• W2005040232 hasConcept C141071460 @default.
• W2005040232 hasConcept C164705383 @default.
• W2005040232 hasConcept C2775901492 @default.
• W2005040232 hasConcept C2776820930 @default.
• W2005040232 hasConcept C2778213512 @default.
• W2005040232 hasConcept C2778881276 @default.
• W2005040232 hasConcept C31174226 @default.
• W2005040232 hasConcept C42219234 @default.
• W2005040232 hasConcept C500558357 @default.
• W2005040232 hasConcept C71924100 @default.
• W2005040232 hasConceptScore W2005040232C126322002 @default.
• W2005040232 hasConceptScore W2005040232C141071460 @default.
• W2005040232 hasConceptScore W2005040232C164705383 @default.
• W2005040232 hasConceptScore W2005040232C2775901492 @default.
• W2005040232 hasConceptScore W2005040232C2776820930 @default.
• W2005040232 hasConceptScore W2005040232C2778213512 @default.
• W2005040232 hasConceptScore W2005040232C2778881276 @default.
• W2005040232 hasConceptScore W2005040232C31174226 @default.
• W2005040232 hasConceptScore W2005040232C42219234 @default.
• W2005040232 hasConceptScore W2005040232C500558357 @default.
• W2005040232 hasConceptScore W2005040232C71924100 @default.
• W2005040232 hasIssue "5" @default.
• W2005040232 hasLocation W20050402321 @default.
• W2005040232 hasLocation W20050402322 @default.
• W2005040232 hasOpenAccess W2005040232 @default.
• W2005040232 hasPrimaryLocation W20050402321 @default.
• W2005040232 hasRelatedWork W1580905093 @default.
• W2005040232 hasRelatedWork W2047320516 @default.
• W2005040232 hasRelatedWork W2380434284 @default.
• W2005040232 hasRelatedWork W2387782335 @default.
• W2005040232 hasRelatedWork W2392407047 @default.
• W2005040232 hasRelatedWork W2405170975 @default.
• W2005040232 hasRelatedWork W2417414779 @default.
• W2005040232 hasRelatedWork W2790353319 @default.
• W2005040232 hasRelatedWork W2803154976 @default.
• W2005040232 hasRelatedWork W4235394560 @default.
• W2005040232 hasVolume "22" @default.
• W2005040232 isParatext "false" @default.
• W2005040232 isRetracted "false" @default.
• W2005040232 magId "2005040232" @default.
• W2005040232 workType "article" @default.